Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 21, 2007

BioE and Phillips Plastics Join Forces to Enhance Stem Cell Therapeutics

  • BioE and Phillips Plastics will together develop and commercialize stem cell therapeutics for orthopedic applications. These stem cell therapeutics will consist of BioE's Multi-Lineage Progenitor Cell™ (MLPC) stem cells derived from human umbilical cord blood and Phillips Plastics' growth structures.

    "The convergence of medical technologies in the form of biodevice combinations has enormous potential in the orthopedic sector," points out Michael Haider, president and CEO for BioE.

    In early development studies, the MLPC has differentiated into osteoblasts and chondrocytes along with numerous other cell and tissue precursors, BioE reports. Phillips Plastics is developing custom structures to enhance the growth of these cells from the MLPC.

    “These therapeutics could lead to treatments for osteoporosis and bone fractures of the hip, spine, wrist, arm, and leg as well as remedies for injured or deteriorated joints throughout the body," Haider adds.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »